Article

Acute cholecystitis – early laparoskopic surgery versus antibiotic therapy and delayed elective cholecystectomy: ACDC-study

Department of General Surgery, University of Heidelberg, Germany.
Trials (Impact Factor: 2.12). 02/2007; 8:29. DOI: 10.1186/1745-6215-8-29
Source: PubMed

ABSTRACT Background
Acute cholecystitis occurs frequently in the elderly and in patients with gall stones. Most cases of severe or recurrent cholecystitis eventually require surgery, usually laparoscopic cholecystectomy in the Western World. It is unclear whether an initial, conservative approach with antibiotic and symptomatic therapy followed by delayed elective surgery would result in better morbidity and outcome than immediate surgery. At present, treatment is generally determined by whether the patient first sees a surgeon or a gastroenterologist. We wish to investigate whether both approaches are equivalent. The primary endpoint is the morbidity until day 75 after inclusion into the study.

Design
A multicenter, prospective, randomized non-blinded study to compare treatment outcome, complications and 75-day morbidity in patients with acute cholecystitis randomized to laparoscopic cholecystectomy within 24 hours of symptom onset or antibiotic treatment with moxifloxacin and subsequent elective cholecystectomy. For consistency in both arms moxifloxacin, a fluorquinolone with broad spectrum of activity and high bile concentration is used as antibiotic. Duration: October 2006 – November 2008

Organisation/Responsibility
The trial was planned and is being conducted and analysed by the Departments of Gastroenterology and General Surgery at the University Hospital of Heidelberg according to the ethical, regulatory and scientific principles governing clinical research as set out in the Declaration of Helsinki (1989) and the Good Clinical Practice guideline (GCP).

Trial Registration
ClinicalTrials.gov NCT00447304

Download full-text

Full-text

Available from: Kilian Weigand, Sep 03, 2015
0 Followers
 · 
304 Views
 · 
51 Downloads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Chirurgische multizentrische randomisiert-kontrollierte Studien (MRCT) in Deutschland können nach Prüfung von definierten Aufnahmekriterien seit genau einem Jahr in der Rubrik ,,Klinische Studien“ in Form einer monatlich aktualisierten Studienliste aufgenommen werden.Eine quantitative und qualitative Analyse der in der Studienliste aufgeführten MRCT und damit der Entwicklung der Rubrik ,,Klinische Studien“ wurde als Zwischenbilanz nach einem Jahr der Rubrik durchgeführt.Die Studienliste ist von initial 4 auf aktuell 11 MRCT angewachsen, die aufgeführten eingeschlossenen Patienten sind von 396 auf aktuell 1511 gestiegen. Es gibt deutliche Unterschiede hinsichtlich der finanziellen Förderung und des Fallgeldes für Patienten in den einzelnen Studien. Von 4 der 11 MRCT sind ausführliche Protokollpublikationen in wissenschaftlichen Zeitschriften publiziert.Die neue Rubrik ,,Klinische Studien“ ist im 1. Jahr des Bestehens deutlich gewachsen und liefert wichtige Details über laufende MRCT in der Chirurgie. Ein stetiges Wachstum von aufgeführten Studien und rekrutierten Patienten demonstriert die Praktikabilität der Durchführung von chirurgischen MRCT in Deutschland.
    Der Chirurg 01/2008; 79(4). · 0.52 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: For 1 year now, German surgical multicentric randomised controlled trials (MRCT) in Germany may be included under the heading "Clinical Trials" in our monthly updated trial list. Quantitative and qualitative analysis of MRCT presented in the trial list was performed to give an overview and interim statement 1 year after implementation of the journal heading "Clinical Trials". In 1 year, the study list increased from four to eleven MRCT and the numbers of randomized patients from 396 to 1511. The MRCT show distinct differences regarding funding sources and reimbursement for participating centres per patient included. The study protocols of four of 11 MRCT were published in scientific journals. The new regular heading gives important details about ongoing surgical trials in Germany. The steady growth of trials and recruited patients demonstrates the practicability of randomized controlled trials in surgery.
    Der Chirurg 05/2008; 79(4):361-4. DOI:10.1007/s00104-008-1508-8 · 0.52 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Symptomatic gallstone disease is the second most common abdominal emergency in pregnant women. There have been significant developments in the management of gallstone disease, but risk to the fetus has prevented their routine application in pregnant women. We reviewed the literature to find the current best evidence for the management of gallstones and its complications in pregnancy. MEDLINE and PubMed literature searches were performed to identify original studies. Six studies comparing conservative with surgical management of cholecystitis showed no significant difference in incidence of preterm delivery (3.5% vs 6.0%, P = .33) or fetal mortality (2.2% vs 1.2%, P = .57). There was no maternal or fetal mortality in 20 reports of laparoscopic cholecystectomy and 9 reports of endoscopic retrograde cholangiopancreatography, thus indicating their safety when performed with necessary precautions. Laparoscopic cholecystectomy is a safe procedure in all trimesters. In 12 reports of gallstone pancreatitis, fetal mortality was 8.0% versus 2.6% (P = .28) in conservative and surgical groups, respectively, suggesting the need for earlier surgical intervention.
    American journal of surgery 08/2008; 196(4):599-608. DOI:10.1016/j.amjsurg.2008.01.015 · 2.41 Impact Factor
Show more